ClinicalTrials.Veeva

Menu

Functionality Assessments in Patients (Adults and Children) Following Treatment With Debrase Compared to Standard of Care

M

MediWound

Status

Unknown

Conditions

Burns, Lower Extremity
Burns, Upper Extremity

Study type

Observational

Funder types

Industry

Identifiers

NCT01800981
MW2012-12-12

Details and patient eligibility

About

Once the victim survived the acute phase, the outcome of wound healing, the scarring, became a major medical issue with complications that may lead to cosmetic and functional sequelae. Scar tissue is clinically distinguished from normal skin by an aberrant color, rough surface texture, increased thickness (hypertrophy), contraction, firmness and sometimes, decrease function.

Thus, functional and cosmetic outcomes became at least important as wound closure in assessing wound healing products

Full description

This is a multi-center, assessor-blinded study aiming to evaluate the long term functionality in adults and children who have participated in study MW2004-11-02 (previous phase 3 study).

We had previously shown that by using the MVSS scale which includes objective assessment of the physical characteristics of size, shape, volume, color, texture, and pliability as well as structural, mechanical and physiologic characteristics, lower (favorable) scores in Debrase vs. SOC group were observed in sub-groups of highly functional body parts of the hands and feet. This study will include specific functionality evaluation using the "Lower Extremity Functional Scale" test for burns in the lower extremities and the "QuickDASH" outcome measure for burns in the upper extremities as well as range of motion measurements of the joints (knee, ankle, shoulder, elbow and wrist, as relevant).

Enrollment

53 estimated patients

Sex

All

Ages

10 to 61 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults and children who had participated and completed study MW2004-11-02. Patients must be able to sign and dated written informed consent prior to study entry (by Patient or by a guardian, when applicable).

Exclusion criteria

  • None

Trial design

53 participants in 2 patient groups

Debrase
Description:
Patients previously treated with Debrase for burn debridement
Standard of Care
Description:
Patients previously treated with local Standard of Care for burn debridement

Trial contacts and locations

1

Loading...

Central trial contact

Keren David, MSc; Efrat Hazan, BSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems